We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£88.12
This is the most expensive it has ever been. Walk away.
£88 today · previous high £88 · all-time low £87
CRC Press Biosimilarity: The FDA Perspective - Drug Approval Guide
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 71 days · 71 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 71 days • 2 price levels
Price Analysis
Most common price: £87 (44 days, 62.0%)
Price range: £87 - £88
Price levels: 2 different prices over 71 days
Description
Key Features
CRC Press provides comprehensive analysis grounded in actual FDA guidelines and approval packages from multiple biosimilar products.
Covers non-inferiority testing methodologies designed to reduce the need for extensive patient trials in biosimilar development.
Examines immunogenicity testing approaches and strategies to minimise unnecessary testing whilst maintaining safety standards.
Includes scientific, mathematical and statistical frameworks essential for establishing biosimilarity across different biological drug complexities.
Addresses statutory limitations affecting biosimilar approval, offering practical solutions for regulatory compliance.
Product Specifications
- Brand
- CRC Press
- Format
- hardcover
- ASIN
- 1498750397
- Domain
- Amazon UK
- Release Date
- 04 August 2016
- Listed Since
- 04 November 2015
Barcode
No barcode data available
Similar Products You Might Like
Biosimilars and Interchangeable Biologics: Strategic Elements
CRC Press
Price unavailable
CRC Press Biosimilars Development Strategies Book
CRC Press
Biosimilars and Interchangeable Biologics: Tactical Elements
CRC Press
Biosimilars and Interchangeable Biologics: Strategic Elements
CRC Press
Biosimilars and Interchangeable Biologics: Tactical Elements
CRC Press
Biosimilars: A New Generation of Biologics
Springer
Biosimilars: A New Generation of Biologics
Springer
Biosimilar Drug Product Development - CRC Press Guide
CRC Press
ASHP Biosimilars and Biologics - Healthcare Implementation Guide
American Society of Health-System Pharmacists
Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set
CRC Press
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
Elsevier
Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)
CRC Press
Biologics and Biosimilars: Drug Discovery and Clinical Applications
CRC Press
Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Commercialization of BioPharma Products in the USA (BW): A Practical Guide
Rxcommercial Research International, Incorporated
Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians and Other Health Practitioners
Wiley
Analytical Similarity Assessment in Biosimilar Product Development
CRC Press
Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
CRC Press
Artificial Intelligence for Drug Product Lifecycle Applications
Elsevier
Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead
CRC Press
Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide
World Scientific Publishing Company
Development and Evaluation of Drugs: From Laboratory through Licensure to Market
CRC Press
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Springer